SCHEMBL2808775

SCHEMBL2808775

COc1ccccc1O/C=C(C)/C(=N/c1ccc(C)cc1)Sc1cccc(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 4/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
KMT2A Q03164 4/20 0.33
RAB9A P51151 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
MEN1 O00255 3/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
QRFPR Q96P65 1/20 0.32
PLAU P00749 1/20 0.32
PRSS1 P07477 1/20 0.32
ACR P10323 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808778 1.00 MAPT (0.36) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2810735 0.94 HTR3E (0.33) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL12851014 0.94 HTR3E (0.33) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2810734 0.94 HTR3E (0.33) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2813255 0.91 MAPT (0.41) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2813258 0.91 MAPT (0.41) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2810516 0.86 NOS3 (0.37) MAPTHPGDALDH1A1KMT2ARAB9A
SCHEMBL2810517 0.86 NOS3 (0.37) MAPTHPGDALDH1A1KMT2ARAB9A
SCHEMBL2808844 0.85 ACHE (0.38) MAPTHPGDALDH1A1KMT2ARAB9A
SCHEMBL2808850 0.85 ACHE (0.38) MAPTHPGDALDH1A1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 MAPT 4608/4885HPGD 2145/4885HSD17B10 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.